Ticker Details
Climb Bio, Inc. Common Stock
IPO Date:	August 10, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$791.37M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.86%
Avg Daily Range (30 D):	$0.55 | 4.50%
Avg Daily Range (90 D):	$0.41 | 4.17%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	1.23M
Avg Daily Volume (90 D):	.83M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	96
Avg Trade Size (Sh.) (90 D):	91

Institutional Trades
Total Institutional Trades:	156
Avg Institutional Trade:	$1.93M
Avg Institutional Trade (30 D):	$2.56M
Avg Institutional Trade (90 D):	$1.95M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.25M
Avg Closing Trade (30 D):	$4.02M
Avg Closing Trade (90 D):	$3.09M
Avg Closing Volume:	360.09K

News

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Feb 5, 2026 @ 12:00 PM Climb Bio to Present at Upcoming Investor Conferen... Source: Not Specified

Nov 25, 2025 @ 12:00 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Carlo Tanzi, Ph.D.

Oct 17, 2025 @ 11:00 AM Climb Bio to Present Data at American Society of N... Source: Climb Bio, Inc.

Aug 25, 2025 @ 6:41 PM UPDATE – Climb Bio to Present at Upcoming S... Source: Carlo Tanzi, Ph.D.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.77	$-.2	$-.25
Diluted EPS	$-.77	$-.2	$-.25
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-52.79M	$-13.72M	$-17.52M
Operating Income / Loss	$-60.08M	$-15.21M	$-19.3M
Cost of Revenue
Net Cash Flow	$-78.87M	$-27.33M	$-51.54M
PE Ratio